Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck

Head & Neck

Volumn 17, Issue 4, 1995, Pages 312-318

  Zätterström, Ulf K ^a   Brun, Eva ^a   Willén, Roger ^a   Kjellén, Elisabeth ^a   Wennerberg, Johan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; MITOMYCIN; MITOMYCIN C; POLYCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0029074706     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.2880170407     Document Type: Article

References (33)

1. Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder
2. The significance of atypical vessels and neovascularization in cervical neoplasia
3. Angiogenesis induced by “normal” human breast tissue: a probable marker for precancer
4. Endothelial cells and angiogenic growth factors in cancer growth and metastasis: Introduction
5. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor‐associated macrophages
6. Angiogenic factors
7. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation
8. Angiogenesis
9. Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model
10. Synthetic analogue of fumagillin that inhibit angiogenesis and suppress tumour growth
11. Angiogenesis and its inhibition: potential new therapies in oncology and non‐neoplastic diseases
12. Inhibitory effect of medroxyprogesteron acetate on angiogenesis induced by human endometrial cancer
13. Tumor angiogenesis: a new significant and independent prognostic indicator in early‐stage breast carcinoma
14. The prognostic significance of tumour vascularity in intermediate‐thickness (0.76–4.0 mm thick) skin melanoma: a quantitative histologic study
15. Vascularization of malignant testicular tumors
16. Relation of neovascularisation to metastasis of non‐small‐cell lung cancer
17. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
18. Intratumoral microvessel density and p53 protein: correlation with metastasis in head‐and‐neck squamous‐cell carcinoma
19. Tumor angiogenesis: therapeutic implications
20. Tumor angiogenesis: review of current applications in tumor prognostication
21. Inadequate vasculature in solid tumours: consequences for cancer research strategies
22. Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy
23. Variation of vascular density within and between tumours of the uterine cervix and its predictive value for radiotherapy
24. Vascularization and curability of stage III and IV nasopharyngeal tumors
25. Histologic classification and grading of malignancy in carcinoma of the larynx
26. DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis
27. Prognostic variables in head and neck cancer–tumour site, stage, nodal status, differentiation, and immune status
28. Discriminant analysis in predicting survival of patients with cancer of the larynx or hypopharynx
29. Prognostic factors in head and neck cancer: histologic grading, DNA ploidy and nodal status
30. Cancer of the head and neck region
31. Prognosis in laryngeal carcinoma: host factors
32. The value of follow‐up in patients treated for squamous cell carcinoma of the head and neck